The CPPA Telehealth Pharmacy Practice Accreditation, administered by the National Association of Boards of Pharmacy® (NABP®), was recently awarded to the Austin, TX and Gainesville, FL locations of SinfoníaRx
TRHC announces the appointment of Kevin Boesen, PharmD, as Chief Sales Officer, responsible for all direct and channel sales efforts in the United States and Canada.
SinfoníaRx announces a new generation of proprietary MTM software, RxCompanion™ 10.0
SinfoníaRx earns a spot on the list of 2018 azcentral.com® Top Companies to Work for in Arizona for the third consecutive year.
SinfoníaRx congratulates 2018 PQA Quality Award recipient, Dean Health Plan, for their dedication to comprehensive patient care through innovative solutions.
SinfoníaRx publishes its 2018 Program Performance Report, presenting a comprehensive analysis of calendar-year 2017.
SinfoníaRx has long supported high school students by offering comprehensive on-the-job experience. One graduating SinfoníaRx high school intern, J. Martin Peralta, shares his inspiring story of perseverance.
Student Pharmacists at The University of Texas at Austin to receive cutting-edge experiential education in Medication Therapy Management.
SinfoníaRx announces partnership with The Health Plan of San Mateo (HPSM), a nonprofit County Organized Health System that offers medical and support services for Medi-Cal eligible residents in San Mateo County, California.
HITRUST CSF Certified status indicates that RxCompanion™, SinfoníaRx’s proprietary MTM solution platform, has met industry-defined requirements and is appropriately managing risk. This achievement places SinfoníaRx among an elite group of organizations worldwide that have earned this certification.
SinfoníaRx is excited to announce a recent development within the company – we are now a wholly-owned subsidiary of renowned Tabula Rasa HealthCare.
The Center for Pharmacy Practice Accreditation (CPPA) recently accredited SinfoníaRx Inc., a healthcare company that provides high-quality healthcare solutions for health plans, patients, and caregivers.
During a session at the Academy of Managed Care Pharmacy 2016 Nexus meeting, Nicole Scovis, PharmD, BCPS, BCACP, and Sandra Leal, PharmD, MPH, both of SinfoníaRx in Tucson, Arizona, explained how precision medicine can be integrated into primary care practice to improve care.
The award sponsored by the Tucson Chamber, WellsFargo, and Nextrio honors businesses that are technology-led and/or look to IT to solve problems and increase efficiency.
Medication therapy management (MTM) technology developed by SinfoníaRx has expanded to support the growing Hispanic population that has reached nearly 57 million in the US. To help improve the treatment of chronic conditions in Hispanic populations, SinfoníaRx has launched a new call center located in the Phoenix area.“Prescriptions with a goal ‐ partners in your health” or “Recetas con metas ‐ compañeros en su salud “ is SinfoníaRx’s clinical program focused on the Spanish speaking patient. SinfoníaRx’s Spanish speaking MTM providers are internationally recognized and experts in complex and chronic disease management.
SinfoníaRx announced that it has been awarded Drug Therapy Management Accreditation from URAC, a Washington, DC based health care accrediting organization that establishes quality standards for the healthcare industry. URAC’s DTM Accreditation standards assess a range of professional activities, including formulating medication treatment plans, monitoring efficacy and safety of medication therapy and enhancing medication adherence through patient empowerment and education.
SinfoníaRx and AltheaDx announced today an agreement to integrate AltheaDx’s IDgenetix® proprietary genetic testing into SinfoníaRx’s medication therapy management (MTM) programs. MTM is a personalized service delivered by pharmacists designed to optimize health outcomes through improved medication treatment. Through the use of the AltheaDx’s IDgenetix® genetic testing, the service will provide an unprecedented level of drug therapy optimization and customization for individual patients.
Medication therapy management (MTM) technology developed by SinfoníaRx will now be utilized by Walmart pharmacies to improve patient health outcomes. SinfoníaRx’s technology, originally developed by researchers and faculty at the University of Arizona College of Pharmacy, is currently used by pharmacists at the University of Arizona and The Ohio State University to monitor prescription use for approximately 300 health plans representing more than 6 million patients nationally.
SinfoníaRx, a division of Sinfonia HealthCare Corporation a national company founded by Fletcher J. McCusker, former CEO and founder of Providence Service Corporation (NASDAQ‐PRSC), announced today that data produced by their Medication Therapy Management (MTM) program has identified potential medication‐‐‐related problems in 1 of 3 seniors with multiple chronic illnesses. SinfoníaRx is one of the nation’s largest providers of MTM services currently supporting more than 300 Medicare Part D plans representing more than 5 million Medicare beneficiaries nationwide.
The college’s Medication Management Center was selected to receive a 2013 Pinnacle Award from the American Pharmacists Association (APhA) Foundation. This is a national award that recognizes significant contributions to the process of medication use through increasing patient adherence, reducing drug errors and adverse events, promoting the use of national treatment guidelines, improving patient outcomes, or enhancing communication among the members of the healthcare team.